These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Preprints are manuscripts made publicly available before they have been submitted for formal peer review and publication. They might contain new research findings or data. Preprints can be a draft or final version of an author's research but must not have been accepted for publication at the time of submission.
revised on 10.02.2019 and posted on 11.02.2019by Joseph Gair, Brandon E. Haines, Alexander S. Filatov, Djamaladdin G. Musaev, Jared C. Lewis
The role of mono-protected amino acid (MPAA) ligands in accelerating enantioselective cyclopalladation and palladium catalyzed C-H func-tionalization was investigated using kinetic, spectroscopic, and computational methods. Single crystal X-ray diffraction and NMR spectroscopy demonstrate that MPAA ligands bind catalytically competent di-palladium complexes as bridging carboxylates. The catalytic relevance of the observed di-palladium species was evaluated by kinetic analysis. The kinetic method of continuous variation demonstrated that a complex contain-ing a single MPAA-bridged di-palladium core (Pd2(MPAA)1) is an active catalyst for the reactions studied. The experimental studies are con-sistent with density functional theory calculations that indicate enantioinduction can be achieved by a single MPAA ligand bridging a di-palladium catalyst through secondary sphere hydrogen-bonding interactions that lower the barrier to C-H activation of the major enantiomer.